Hidradenitis Suppurativa and Crohn's Disease: A Case Series

S Kirthi1,2, R Hellen1, R O'Connor1

  • 1Department of Dermatology, The Adelaide and Meath Hospital, Dublin.

Irish Medical Journal
|November 24, 2017
PubMed

Insights

This study identified an Irish cohort with Hidradenitis Suppurativa (HS) and Crohn's Disease (CD). Combined HS and CD patients often smoked and had increased BMI, but TNF-alpha inhibitors improved HS outcomes.

Area of Science:

  • Dermatology
  • Gastroenterology
  • Immunology

Background:

  • Hidradenitis Suppurativa (HS) presents with chronic abscesses and sinus tracts.
  • Cutaneous Crohn's Disease (CD) can mimic HS symptoms.
  • Understanding the overlap between HS and CD is crucial for diagnosis and management.

Purpose of the Study:

  • To identify and characterize an Irish cohort with co-occurring HS and CD.
  • To better recognize clinical manifestations of combined HS and CD.
  • To gain insights into the pathophysiology of these overlapping conditions.

Main Methods:

  • Retrospective review of patients diagnosed with HS and CD between 1990-2014 at Tallaght Hospital.
  • Utilized HIPE Code for case identification.
  • Analyzed demographic, clinical, and treatment data.

Main Results:

  • Seven patients with both HS and CD were identified (5/7 female).
  • The median age at diagnosis for both conditions was 37 years, with CD preceding HS.
  • All patients smoked, 6 had increased BMI, and 43% had other autoimmune conditions.
  • TNF-alpha inhibitor treatment for HS led to reduced flare-ups and clinical activity in 5/6 patients.

Conclusions:

  • Combined HS and CD is observed in an Irish population, with specific demographic and risk factor profiles.
  • CD diagnosis consistently preceded HS diagnosis in this cohort.
  • TNF-alpha inhibitors demonstrate efficacy in managing HS in patients with co-existing CD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
820
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
602
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
935
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
561